AREX Capital Releases Presentation Detailing Its Nominees’ Comprehensive Plan to Deliver Enduring Value for Enhabit Stockholders

Rhea-AI Summary

AREX Capital Management, LP, which owns 4.9% of Enhabit’s outstanding common shares, has released a presentation outlining a comprehensive plan to improve Enhabit’s operational performance.

The plan includes recapturing home health market share, revamping hospice sales, and reducing corporate overhead, with an anticipated 50% increase in EBITDA. AREX is urging stockholders to vote for its seven nominees using the WHITE Proxy Card at the 2024 Annual Meeting.

AREX believes their nominees possess the necessary experience and skills to oversee management and drive significant value creation for Enhabit’s stockholders.

Further details are available at www.RehabEHAB.com.

Positive

• AREX's plan aims to increase Enhabit’s EBITDA by 50%.
• The focus on recapturing home health market share and revamping hospice sales could bolster revenue.

Negative

• The need to reduce corporate overhead may indicate current inefficiencies.

Presentation Details the AREX Slate’s Achievable Plan to Improve Enhabit’s Operational Performance, Recapture Home Health Market Share, Revamp Hospice Sales, and Reduce Corporate Overhead

Believes AREX Slate’s Plan Can Increase EBITDA by 50%

Visit www.RehabEHAB.com to Download the Presentation and Learn How to Vote the WHITE Proxy Card for All Seven Members of the AREX Slate

NEW YORK--(BUSINESS WIRE)-- AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), today issued a presentation detailing the AREX Slate’s comprehensive plan to turn around Enhabit’s operational performance and reduce costs, which AREX believes could increase EBITDA by 50%.

The presentation can be accessed here: Rehabilitate Enhabit.

As a reminder, AREX encourages stockholders to vote for all seven of its highly qualified nominees on the WHITE Proxy Card at the upcoming 2024 Annual Meeting of Stockholders. AREX believes this is the only way to ensure that Enhabit has a Board of Directors with the right experience and skills to effectively oversee management and help them drive operational improvements that can lead to significant value creation for stockholders.

About AREX

AREX Capital Management, LP is a value-oriented investment firm based in New York City. AREX takes a long-term, opportunistic approach to investing and focuses primarily on publicly traded companies with significant, unrealized potential.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240627017218/en/

Investor Contact



Saratoga Proxy Consulting

John Ferguson

(212) 257-1311

rehabEHAB@saratogaproxy.com



Media Contact



Longacre Square Partners

Charlotte Kiaie / Bela Kirpalani

(646) 386-0091

rehabEHAB@longacresquare.com

Source: AREX Capital Management, LP

FAQ

What is AREX Capital's plan for Enhabit (EHAB) stockholders?

AREX Capital has released a plan to improve Enhabit’s operational performance, aiming to increase EBITDA by 50%, recapture home health market share, revamp hospice sales, and reduce corporate overhead.

How much of Enhabit (EHAB) does AREX Capital own?

AREX Capital owns approximately 4.9% of Enhabit’s outstanding common shares.

What actions does AREX Capital recommend for Enhabit (EHAB) stockholders?

AREX Capital recommends stockholders vote for its seven nominees on the WHITE Proxy Card at the 2024 Annual Meeting.

How can Enhabit (EHAB) stockholders access the AREX Capital presentation?

Stockholders can access the AREX Capital presentation at www.RehabEHAB.com.

What is the goal of AREX Capital’s plan for Enhabit (EHAB)?

The goal of AREX Capital's plan is to enhance operational performance and create significant value for Enhabit’s stockholders.